Infliximab and amyloidosis secondary to inflammatory bowel diseases [5] (multiple letters)

  1. Callejas Rubio, J.L.
  2. Ortego Centeno, N.
  3. Cárdeña Péez, C.
  4. Navas-Parejo, A.
  5. Casellas, F.
Revue:
Medicina Clinica

ISSN: 0025-7753

Année de publication: 2005

Volumen: 124

Número: 19

Pages: 757-758

Type: Article

DOI: 10.1157/13075451 GOOGLE SCHOLAR

Objectifs de Développement Durable